PDCD1 and gastrointestinal stromal tumor: Several clinical studies have investigated the therapeutic efficacy of PD1/PD-L1 inhibitors or their combinations with chemicals or antibodies in GIST [34, 238–241], but the results are unsatisfactory: most patients did not respond to these therapies and quite a few patients achieved PR or SD.